Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 9483

Tamarac, Fl 33319

Study Summary:

A multicenter, randomized, active-control, phase 3b study to evaluate the cardiovascular safety of febuxostat and allopurinol in subjects with gout and cardiovascular comorbidities.

The subject or the subject’s legally acceptable representative signs and dates a written, informed consent form/Health Insurance Portability and Accountability Act (HIPAA) Authorization prior to the initiation of any study procedures.

2. The subject is male ≥50 years of age or female ≥55 years of age and at least 2-years post-menopausal.

3. The subject has a history or presence of gout defined as having one or more of the American Rheumatism Association criteria for the diagnosis of gout [13]

Qualified Participants May Receive:


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.